BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17940395)

  • 1. [An octogenarian case of postoperative recurrent lung cancer responding to treatments with radiation plus gefitinib].
    Hanaoka T; Sone S; Yamaguchi S; Okada M; Hayano T
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1701-3. PubMed ID: 17940395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of postoperative recurrent lung cancer with long survival due to gefitinib efficacy].
    Okagawa T; Uchida T; Suyama M
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1841-3. PubMed ID: 18030020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thai female non-smoker with recurrent lung adenocarcinoma who has dramatic and prolonged response to gefitinib for over one year.
    Charoentum C
    J Med Assoc Thai; 2006 Jun; 89(6):882-6. PubMed ID: 16850692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dramatic responses to gefitinib when used as front line therapy in two cases of metastatic lung adenocarcinoma with poor performance status.
    Gupta A; Raina V; Garg P; Kumar R
    J Cancer Res Ther; 2010; 6(3):362-4. PubMed ID: 21119278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Two lung adenocarcinoma patients with multiple brain metastasis treated with Gefitinib and surviving more than 2 years].
    Matsuyama W; Yamamoto M; Machida K; Mitsuyama H; Watanabe M; Higashimoto I; Osame M; Arimura K
    Nihon Kokyuki Gakkai Zasshi; 2006 Sep; 44(9):653-8. PubMed ID: 17037411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successful gefitinib every other day administration in an advanced lung cancer patient with brain metastasis after gamma knife radiotherapy and chemotherapy].
    Tomisaki S; Takenaka T; Morizono G; Tanaka T; Momosaki N; Inoue F
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2607-10. PubMed ID: 20009463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of complete response in a primary lesion treated by gefitinib for two years after surgery of brain metastasis from lung cancer].
    Matsuoka T; Morikage N; Kuga T; Nakayama T; Fujii Y
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):497-500. PubMed ID: 16612160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of the efficacy and safety of gefitinib in the treatment of recurrent advanced non-small cell lung cancer in an expanded access program (EAP)].
    Huang H; Zhang Y; Zhao HY; Wang ZQ; Xu F; Xu GC; Zhang L; Guan ZZ
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):148-51. PubMed ID: 19538895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gefitinib as first-line, compassionate use therapy in patients with advanced non-small-cell lung cancer.
    Argiris A; Mittal N
    Lung Cancer; 2004 Mar; 43(3):317-22. PubMed ID: 15165090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes after first-line EGFR inhibitor treatment for patients with NSCLC, EGFR mutation, and poor performance status.
    Okuma Y; Hosomi Y; Nagamata M; Yamada Y; Sekihara K; Kato K; Hishima T; Okamura T
    Anticancer Res; 2013 Nov; 33(11):5057-64. PubMed ID: 24222150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gefitinib and a ventriculo-peritoneal shunt to manage carcinomatous meningitis from non-small-cell lung cancer: report of two cases.
    So T; Inoue M; Chikaishi Y; Nose N; Sugio K; Yasumoto K
    Surg Today; 2009; 39(7):598-602. PubMed ID: 19562448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gefitinib Monotherapy Afforded Long-Term Survival of an Octogenarian Patient with a Postoperative Recurrence of a Pulmonary Adenocarcinoma-A Case Report].
    Kamiyoshihara M; Igai H; Ohsawa F; Numajiri K
    Gan To Kagaku Ryoho; 2023 Feb; 50(2):187-189. PubMed ID: 36807168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Successful Treatment of a Mechanically Ventilated Patient with an Oncological Emergency Caused by Recurrence of Pulmonary Adenocarcinoma].
    Kamiyoshihara M; Yoshikawa R; Igai H; Matsuura N; Ohsawa F; Yazawa T
    Gan To Kagaku Ryoho; 2019 Dec; 46(12):1895-1897. PubMed ID: 31879411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial of gefitinib monotherapy in chemotherapy-naïve patients of 75 years or older with advanced non-small cell lung cancer.
    Ebi N; Semba H; Tokunaga SJ; Takayama K; Wataya H; Kuraki T; Yamamoto H; Akamine SJ; Okamoto I; Nakanishi Y;
    J Thorac Oncol; 2008 Oct; 3(10):1166-71. PubMed ID: 18827614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of advanced adenocarcinoma of the lung which maintained complete response for 5 years by treatment with gefitinib].
    Matsuzaki T; Terashima T; Ogawa R; Naitou A; Miyauchi J; Morishita T
    Nihon Kokyuki Gakkai Zasshi; 2010 Aug; 48(8):600-3. PubMed ID: 20803978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations: implications of sensitive EGFR mutation test.
    Choi MK; Hong JY; Chang WJ; Kim MJ; Kim SM; Jung HA; Do IG; Choi YL; Sun JM; Ahn JS; Park K; Ahn MJ
    Cancer Chemother Pharmacol; 2015 Jun; 75(6):1229-36. PubMed ID: 25903122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gefitinib as a first-line therapy of advanced or metastatic adenocarcinoma of the lung in never-smokers.
    Lee DH; Han JY; Lee HG; Lee JJ; Lee EK; Kim HY; Kim HK; Hong EK; Lee JS
    Clin Cancer Res; 2005 Apr; 11(8):3032-7. PubMed ID: 15837758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of meningeal carcinomatosis of lung adenocarcinoma well controlled by re-treatment with gefitinib].
    Kumamoto T; Suetsugu T; Iwakawa J; Tanoue A; Kawamata Y
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2615-7. PubMed ID: 20009465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patients.
    Chang GC; Tsai CM; Chen KC; Yu CJ; Shih JY; Yang TY; Lin CP; Hsu JY; Chiu CH; Perng RP; Yang PC; Yang CH
    J Thorac Oncol; 2006 Jul; 1(6):520-5. PubMed ID: 17409911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.